Stimulants are the best and most common type of medication used to treat ADHD.
This report contains market size and forecasts of ADHD Medication in Global, including the following market information:
Global ADHD Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global ADHD Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ADHD Medication include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Inc, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADHD Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ADHD Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global ADHD Medication Market Segment Percentages, by Type, 2021 (%)
Stimulant
Non-stimulant
Global ADHD Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global ADHD Medication Market Segment Percentages, by Application, 2021 (%)
Attention Deficit
Hyperactivity/impulse Control Disorder
Hybrid
Global ADHD Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global ADHD Medication Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ADHD Medication revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies ADHD Medication revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma, Inc
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengda Fenghai